Paramount Group, Inc.
—- Market cap
- —
- Debt
- +$3.86B
- Cash
- −$375.06M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: PGRE stock price vs BMY: inconclusive — current versus $9.67 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BMY's multiple
Implied fair value · at PGRE's multiple
Needs PGRE P/S.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PGRE FY 2024 (ended Dec 31, 2024) · BMY FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
11 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 74% equity / 26% debt · EV / Revenue 3.60x · EV / EBITDA 11.15x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
PARAMOUNT GROUP, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
BRISTOL-MYERS SQUIBB COMPANY · implied price per share
Bear
$59.11
Base
$72.93
Bull
$92.88
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.23x
2.55x
Net debt / EBITDA
Leverage against operating earnings
28.53x
2.37x
Cash and equivalents
Liquid reserves on the balance sheet
$375.06M
$10.21B
Total debt
Interest-bearing obligations outstanding
$3.86B
$47.09B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BXP, Inc.
PGRE vs BXP
SL GREEN REALTY CORP
PGRE vs SLG
VORNADO REALTY TRUST
PGRE vs VNO
KILROY REALTY CORP
PGRE vs KRC
ALEXANDRIA REAL ESTATE EQUITIES, INC.
PGRE vs ARE
Pfizer Inc.
PGRE vs PFE
Merck & Co., Inc.
PGRE vs MRK
AbbVie Inc.
PGRE vs ABBV
Eli Lilly and Company
PGRE vs LLY
Amgen Inc.
PGRE vs AMGN
Gilead Sciences, Inc.
PGRE vs GILD
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.